世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

臨床ワークフローソリューション市場:製品別(データ統合、ナースコールシステム、ラウンドソリューション、患者フロー管理、エンタープライズレポーティング)、エンドユーザー別(病院、長期ケア、外来ケアセンター)、地域別 2030年までの世界予測


Clinical Workflow Solutions Market by Product (Data Integration, Nurse Call Systems, Rounding Solutions, Patient Flow Management, Enterprise Reporting), End Users (Hospitals, Long-term Care, Ambulatory Care Centers) & Region Global Forecast up to 2030

病院や医療施設では現在、医療スタッフの管理、管理業務や反復的な文書作成ルーチンの統合、患者の管理データや臨床データへの部門全体でのシンプルなアクセスが行われています。さらに、複数の病院やその分院間... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
IHR Insights
アイエイチアールインサイト
2023年11月13日 US$4,500
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
92 英語

 

サマリー

病院や医療施設では現在、医療スタッフの管理、管理業務や反復的な文書作成ルーチンの統合、患者の管理データや臨床データへの部門全体でのシンプルなアクセスが行われています。さらに、複数の病院やその分院間でのデータ共有が必要であり、相互運用可能で高品質なソリューションの必要性が高まっています。臨床ワークフローシステムに対するニーズは、患者中心のケア提供と臨床医の生産性向上に対する介護者の要求によって著しく高まっている。官民の多くの組織が臨床ワークフロー管理システムの重要性を認めている。さらに、臨床センターは臨床意思決定支援システムと電子カルテ(EHR)のインストールと統合を奨励するプログラムを開始している。このため、病院がこれらのサービスを利用するようになり、臨床ワークフロー・ソリューションの市場に有益な効果をもたらすと期待されている。
臨床ワークフロー・ソリューションは、患者の転帰と安全性を高めるためのより魅力的でシームレスかつ効果的な方法を求める医療関連企業の間で、ますます人気が高まっている。なぜなら、これらのソリューションによってリアルタイムの健康データが継続的に流れ、患者ケアに関するより多くの情報に基づいた意思決定と結果につながるからである。臨床ワークフロー・ソリューションは、治療の質、ケアの連携、患者の満足度を向上させるとともに、投薬ミスや薬物有害事象の可能性を低減させる資質を備えているため、今後数年で普及が進むと予想される。
病院におけるITシステム導入の大きな障壁のひとつは、有能なスタッフの不足である。医療ITへの取り組みが増えるにつれ、医療業界のサプライヤーや組織は、有能な従業員を確保することが難しくなっている。米国や欧州のような先進地域でも、発展途上地域でも、医療IT人材の不足が顕著になっている。そのため、市場拡大の大きな障害となっているのが、有能な専門家の不足である。
製品別臨床ワークフローソリューション市場
- データ統合
- リアルタイム通信ソリューション
- ワークフロー自動化ソリューション
- ケアコラボレーションソリューション
- エンタープライズレポーティング&分析ソリューション
エンドユーザー別臨床ワークフローソリューション市場
- 病院
- 長期介護施設
- 外来ケアセンター
臨床ワークフローソリューション市場:地域別
- 北米
o 米国
カナダ
- 欧州
o ドイツ
o イギリス
o フランス
o イタリア
o スペイン
o 残りのヨーロッパ(RoE)
- アジア太平洋(APAC)
o 中国
o 日本
o インド
o オーストラリア
o 韓国
o その他のアジア太平洋地域(RoAPAC)
- ラテンアメリカ(LATAM)
o ブラジル
o アルゼンチン
o その他の南米諸国
- 中東・アフリカ(MEA)
o アラブ首長国連邦
o トルコ
o サウジアラビア
o 南アフリカ
o その他の中東・アフリカ
2022年、データ統合ソリューションセグメントの収益シェアは26.4%を超えた。コストの上昇とデータ量の増加を抑えるために統合が必要であることから、データ統合システムは医療サービス提供者の間で最重要の選択肢となっている。医療を受けながら患者の情報を閲覧できる統合システムは、病院やその他の介護事業者に積極的に採用されている。これが2019年のデータ統合システム市場の拡大に拍車をかけた。このセグメントは、相互運用性ソリューション、規制改革と義務化、電子カルテの利用増加、価値ベースのサービスへの重点シフトなどの要因の結果として成長している。
ケアコラボレーションソリューションの市場はここ数年で大きく成長しており、予測期間中に需要が高まると予測される。その背景には、患者中心のサービスへの注目が高まっていることがある。世界的な患者数の増加も、より実用的で効率的なソリューションの開発を業界関係者に促している。ケアマネジメントソリューションは、効率的なワークフロー技術を提供することで、時間とコストを節約しながら患者ケアを強化する。
2022年の臨床ワークフロー・ソリューションの市場シェアは病院が46%を占め、最大となった。これは医療施設の増加と、効果的かつ個人的に管理する必要のある関連データのためである。さらに、このカテゴリの市場拡大は、医療部門におけるデータ処理能力を改善し合理化するために各国政府が実施する支援イニシアティブによって強化されると予想される。例えば、Healthcare Information and Management Systems Society(HIMSS)が2019年に発表したデータによると、60%以上の病院がEHR技術を導入している。さらに、West Health Institute(WHI)は、相互運用性技術の利用拡大が米国の医療費の大幅な減少につながる可能性があると述べている。
さらに、連携病院や効率的な管理ソリューションへの持続的な傾向により、分析期間中に市場は上昇すると予測されている。このセグメントの収益シェアが高い主な理由の1つは、統合された重要な臨床コミュニケーション、統合された協調的なケア提供、簡素化された通話スケジュールプロセスに対する需要の高まりである。
逆に、分析期間中に最も拡大が見込まれるのは外来医療センターである。その主な原因は、外来通院患者の増加である。ITベースのソリューション統合は、医療ミスを大幅に減少させ、外来ケア施設における化学者、医師、看護師、患者の家族間のコミュニケーションを改善する。
北米は2022年に40.7%の市場シェアを占めたが、これは入院患者の増加とヘルスケアソリューションに関連する研究開発努力の結果である。さらに、組織内の情報共有を保護するために医療のデジタル化に費やされる資金が増加していることも、この地域における臨床ワークフローソリューションの拡大の主な要因となっている。
世界の臨床ワークフロー・ソリューション市場の有力企業 Hill-Rom Holdings, Inc.(米国)、Ascom Holding AG(スイス)、Koninklijke Philips N.V.(オランダ)、Cerner Corporation(米国)、Cisco Systems, Inc.(米国)、Stanley Black & Decker, Inc.(米国)、GE Healthcare(米国)、Epic Systems Corporation(米国)、Infor, Inc.(米国)、Allscripts Healthcare Solutions, Inc.(米国)、Spok, Inc.(米国)、Vocera Communications, Inc.(米国)、Capsule Technologies, Inc.(米国)、AMETEK, Inc.(米国)、NextGen Healthcare(米国)、Azure Healthcare Limited(オーストラリア)、Getinge Group(スウェーデン)、Change Healthcare(米国)、athenahealth(米国)、Sonitor Technologies, Inc.(ノルウェー)、Connexall(カナダ)。

- この調査レポートは、自己幹細胞および非幹細胞ベースの治療市場の最も重要な属性を示しており、これが市場を牽引し、機会を提供しています。
- この調査レポートは、臨床ワークフローソリューション市場の成長を市場のいくつかのセグメントに基づいて詳細に分析します。
- 自己幹細胞および非幹細胞ベースの治療市場の過去と現在の動向予測を提示します。
- また、自己幹細胞および非幹細胞ベースの治療市場の主要企業の主要戦略や能力などの競争分析も提示しています。

ページTOPに戻る


目次

Table of Contents
1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Product: Market Size & Analysis
5.1. Overview
5.2. Data Integration
5.3. Real-time Communication Solutions
5.4. Workflow Automation Solutions
5.5. Care Collaboration Solutions
5.6. Enterprise Reporting & Analytics Solutions
5.7. Other Applications
6. End User: Market Size & Analysis
6.1. Overview
6.2. Hospitals
6.3. Long-term care facilities
6.4. Ambulatory care Centers
7. Geography: Market Size & Analysis
7.1. Overview
7.2. North America (U.S., Mexico, Canada)
7.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
7.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
7.5. Latin America (Brazil, Argentina)
7.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
8. Competitive Landscape
8.1. Competitor Comparison Analysis
8.2. Market Developments
8.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
8.2.2. Product Launches and execution
9. Vendor Profiles
9.1. Cerner Corporation
9.1.1. Overview
9.1.2. Financial Overview
9.1.3. Product Offerings
9.1.4. Developments
9.1.5. Business Strategy
9.2. Allscripts Healthcare Solutions, Inc.
9.2.1. Overview
9.2.2. Financial Overview
9.2.3. Product Offerings
9.2.4. Developments
9.2.5. Business Strategy
9.3. NXGN Management, LLC
9.3.1. Overview
9.3.2. Financial Overview
9.3.3. Product Offerings
9.3.4. Developments
9.3.5. Business Strategy
9.4. Koninklijke Philips N.V.
9.4.1. Overview
9.4.2. Financial Overview
9.4.3. Product Offerings
9.4.4. Developments
9.4.5. Business Strategy
9.5. McKesson Corporation
9.5.1. Overview
9.5.2. Financial Overview
9.5.3. Product Offerings
9.5.4. Developments
9.5.5. Business Strategy
9.6. Hill-Rom Services Inc.
9.6.1. Overview
9.6.2. Financial Overview
9.6.3. Product Offerings
9.6.4. Developments
9.6.5. Business Strategy
9.7. General Electric
9.7.1. Overview
9.7.2. Financial Overview
9.7.3. Product Offerings
9.7.4. Developments
9.7.5. Business Strategy
9.8. Cisco
9.8.1. Overview
9.8.2. Financial Overview
9.8.3. Product Offerings
9.8.4. Developments
9.8.5. Business Strategy
9.9. Stanly Healthcare
9.9.1. Overview
9.9.2. Financial Overview
9.9.3. Product Offerings
9.9.4. Developments
9.9.5. Business Strategy
9.10. ASCOM
9.10.1. Overview
9.10.2. Financial Overview
9.10.3. Product Offerings
9.10.4. Developments
9.10.5. Business Strategy

10. Analyst Opinion
11. Annexure
11.1. Report Scope
11.2. Market Definitions
11.3. Research Methodology
11.3.1. Data Collation and In-house Estimation
11.3.2. Market Triangulation
11.3.3. Forecasting
11.4. Report Assumptions
11.5. Declarations
11.6. Stakeholders
11.7. Abbreviations

ページTOPに戻る



図表リスト

Tables
TABLE 1. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 2. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR DATA INTEGRATION, BY GEOGRAPHY , 2021-2030 (USD BILLION)
TABLE 3. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR REAL-TIME COMMUNICATION SOLUTIONS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 4. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR WORKFLOW AUTOMATION SOLUTIONS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 5. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR CARE COLLABORATION SOLUTIONS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 6. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR ENTERPRISE REPORTING & ANALYTICS SOLUTIONS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 7. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 8. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR HOSPITALS, 2021-2030 (USD BILLION)
TABLE 9. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR LONG-TERM CARE FACILITIES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 10. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR AMBULATORY CARE CENTERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 11. NORTH AMERICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 12. NORTH AMERICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 13. NORTH AMERICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 14. U.S CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 15. U.S CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 16. CANADA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 17. CANADA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 18. MEXICO CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 19. MEXICO CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 20. EUROPE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 21. EUROPE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 22. EUROPE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 23. GERMANY CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 24. GERMANY CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 25. U.K CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 26. U.K CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 27. FRANCE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 28. FRANCE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 29. ITALY CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 30. ITALY CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 31. SPAIN CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 32. SPAIN CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 33. ROE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 34. ROE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 35. ASIA PACIFIC CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 36. ASIA PACIFIC CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 37. ASIA PACIFIC CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 38. CHINA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 39. CHINA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 40. INDIA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 41. INDIA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 42. JAPAN CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 43. JAPAN CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 44. REST OF APAC CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 45. REST OF APAC CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 46. LATIN AMERICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 47. LATIN AMERICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 48. BRAZIL CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 49. BRAZIL CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 50. ARGENTINA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 51. ARGENTINA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 52. MIDDLE EAST AND AFRICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 53. MIDDLE EAST AND AFRICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 54. MIDDLE EAST AND AFRICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 55. SAUDI ARABIA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 56. SAUDI ARABIA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 57. UAE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 58. UAE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 59. REST OF MIDDLE EAST AND AFRICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 60. REST OF MIDDLE EAST AND AFRICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 61. CERNER CORPORATION: FINANCIALS
TABLE 62. CERNER CORPORATION: PRODUCTS & SERVICES
TABLE 63. CERNER CORPORATION: RECENT DEVELOPMENTS
TABLE 64. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: FINANCIALS
TABLE 65. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: PRODUCTS & SERVICES
TABLE 66. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: RECENT DEVELOPMENTS
TABLE 67. NXGN MANAGEMENT, LLC: FINANCIALS
TABLE 68. NXGN MANAGEMENT, LLC: PRODUCTS & SERVICES
TABLE 69. NXGN MANAGEMENT, LLC: RECENT DEVELOPMENTS
TABLE 70. KONINKLIJKE PHILIPS N.V.: FINANCIALS
TABLE 71. KONINKLIJKE PHILIPS N.V.: PRODUCTS & SERVICES
TABLE 72. KONINKLIJKE PHILIPS N.V.: RECENT DEVELOPMENTS
TABLE 73. MCKESSON CORPORATION: FINANCIALS
TABLE 74. MCKESSON CORPORATION: PRODUCTS & SERVICES
TABLE 75. MCKESSON CORPORATION: RECENT DEVELOPMENTS
TABLE 76. HILL-ROM SERVICES INC.: FINANCIALS
TABLE 77. HILL-ROM SERVICES INC.: PRODUCTS & SERVICES
TABLE 78. HILL-ROM SERVICES INC.: RECENT DEVELOPMENTS
TABLE 79. GENERAL ELECTRIC: FINANCIALS
TABLE 80. GENERAL ELECTRIC: PRODUCTS & SERVICES
TABLE 81. GENERAL ELECTRIC: DEVELOPMENTS
TABLE 82. CISCO: FINANCIALS
TABLE 83. CISCO: PRODUCTS & SERVICES
TABLE 84. CISCO: RECENT DEVELOPMENTS
TABLE 85. STANLY HEALTHCARE: FINANCIALS
TABLE 86. STANLY HEALTHCARE: PRODUCTS & SERVICES
TABLE 87. STANLY HEALTHCARE: RECENT DEVELOPMENTS
TABLE 88. ASCOM: FINANCIALS
TABLE 89. ASCOM: PRODUCTS & SERVICES
TABLE 90. ASCOM: RECENT DEVELOPMENTS

 

ページTOPに戻る


 

Summary

Hospitals and medical facilities are currently integrating medical staff management, administrative and repetitive documentation routines, and department-wide simple access to patient administrative and clinical data. Additionally, data sharing across multimodal hospitals and their branch offices is necessary, which is driving up the need for interoperable, high-quality solutions. The need for clinical workflow systems has been significantly increased by carers' demands for patient-centered care delivery and increased clinician productivity.Many organisations in the public and private sectors have acknowledged the importance of clinical workflow management systems. Furthermore, clinical centres are launching programmes to encourage the installation and integration of clinical decision support systems and electronic health records (EHRs). This is thus expected to encourage hospitals to use these services, which will have a beneficial effect on the market for clinical workflow solutions.
Clinical workflow solutions are becoming more and more popular among healthcare companies looking for more appealing, seamless, and effective ways to enhance patient outcomes and safety. This is because these solutions make it possible for real-time health data to flow continuously, leading to more informed decisions and outcomes regarding patient care. Clinical workflow solutions are expected to become more popular in the next years because they have qualities that can improve treatment quality, coordination of care, and patient satisfaction while also reducing the likelihood of medication errors and adverse drug events.
One major barrier to the adoption of IT systems in hospitals is the lack of competent staff. The increasing number of healthcare IT efforts is making it difficult for suppliers and organisations in the healthcare industry to locate qualified employees. Both in industrialised regions like the United States and Europe as well as in developing ones, there is now a marked shortage of healthcare IT personnel. Therefore, a major obstacle to the market's expansion is the shortage of qualified professionals.
Clinical Workflow Solutions Market based on Product
• Data Integration
• Real-time Communication Solutions
• Workflow Automation Solutions
• Care Collaboration Solutions
• Enterprise Reporting & Analytics Solutions
Clinical Workflow Solutions Market based on End user
• Hospitals
• Long-term care facilities
• Ambulatory care Centers
Clinical Workflow Solutions Market based on Geography
• North America
o US
o Canada
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe (RoE)
• Asia Pacific (APAC)
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific (RoAPAC)
• Latin America (LATAM)
o Brazil
o Argentina
o Rest of South America
• Middle East and Africa (MEA)
o UAE
o Turkey
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
In 2022, the revenue share of the data integration solutions segment was above 26.4%. The necessity for integration to contain rising costs and growing data quantities has made data integration systems the top choice among healthcare service providers. Integrated systems that let clients view the patient's information while receiving care are being aggressively adopted by hospitals and other carers. This fueled the data integration systems market's expansion in 2019. The segment has grown as a result of factors like interoperability solutions, regulatory reforms and mandates, increased use of electronic medical records, and a shift in emphasis towards value-based services.
The market for care collaboration solutions has grown significantly in the last several years, and demand is predicted to rise during the projected period. The reason for this is the heightened focus on patient-centered services. Growing patient populations worldwide also push industry participants to create more practical and efficient solutions. Care management solutions enhance patient care while saving time and money by offering efficient workflow techniques.
Hospitals held the largest market value share of clinical workflow solutions in 2022—46%—due to the growth in healthcare facilities and the related data that needs to be managed effectively and privately. Furthermore, the market expansion of the category is expected to be bolstered by supporting initiatives implemented by the governments of different countries to improve and streamline the data handling capacity in the healthcare sectors. For instance, more than 60% of hospitals have implemented EHR technology, according to data released by the Healthcare Information and Management Systems Society (HIMSS) in 2019. Moreover, the West Health Institute (WHI) stated that increased usage of interoperability technologies may lead to a significant decrease in US healthcare spending.
Additionally, it is projected that the market would rise during the analysis period due to the persistent trend towards linked hospitals and efficient management solutions. One of the main reasons for the segment's strong revenue share is the growing demand for unified important clinical communications, integrated and collaborative care delivery, and a simplified call scheduling process.
Conversely, it is anticipated that ambulatory care centres will experience the greatest expansion during the course of the analysis. The primary cause of this is an increase in out-patient hospital admissions. IT-based solution integration significantly lowers medical errors and improves communication between chemists, doctors, nurses, and patients' families in ambulatory care facilities.
North America held a 40.7% market share in 2022 as a result of a rise in hospital patient admissions and research and development efforts related to healthcare solutions, both of which increase the amount of data produced and are anticipated to drive market expansion. Additionally, more money being spent on healthcare digitalization to safeguard information sharing inside organisations is a major factor in the expansion of clinical workflow solutions in the area.
The prominent players in the global clinical workflow solutions market Hill-Rom Holdings, Inc. (US), Ascom Holding AG (Switzerland), Koninklijke Philips N.V. (Netherlands), Cerner Corporation (US), Cisco Systems, Inc. (US), Stanley Black & Decker, Inc. (US), GE Healthcare (US), Epic Systems Corporation (US), Infor, Inc. (US), Allscripts Healthcare Solutions, Inc. (US), Spok, Inc. (US), Vocera Communications, Inc. (US), Capsule Technologies, Inc. (US), AMETEK, Inc. (US), NextGen Healthcare (US), Azure Healthcare Limited (Australia), Getinge Group (Sweden), Change Healthcare (US), athenahealth (US), Sonitor Technologies, Inc. (Norway), and Connexall (Canada).

• This report illustrates the most vital attributes of the Autologous Stem Cell and Non-Stem Cell Based Therapies Market, which are driving and providing opportunities.
• This research gives an in-depth analysis of the Clinical Workflow Solutions Market growth on the basis of several segments in the market.
• This report presents the predictions of the past and present trends of the Autologous Stem Cell and Non-Stem Cell Based Therapies Market.
• This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Autologous Stem Cell and Non-Stem Cell Based Therapies Market.



ページTOPに戻る


Table of Contents

Table of Contents
1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Product: Market Size & Analysis
5.1. Overview
5.2. Data Integration
5.3. Real-time Communication Solutions
5.4. Workflow Automation Solutions
5.5. Care Collaboration Solutions
5.6. Enterprise Reporting & Analytics Solutions
5.7. Other Applications
6. End User: Market Size & Analysis
6.1. Overview
6.2. Hospitals
6.3. Long-term care facilities
6.4. Ambulatory care Centers
7. Geography: Market Size & Analysis
7.1. Overview
7.2. North America (U.S., Mexico, Canada)
7.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
7.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
7.5. Latin America (Brazil, Argentina)
7.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
8. Competitive Landscape
8.1. Competitor Comparison Analysis
8.2. Market Developments
8.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
8.2.2. Product Launches and execution
9. Vendor Profiles
9.1. Cerner Corporation
9.1.1. Overview
9.1.2. Financial Overview
9.1.3. Product Offerings
9.1.4. Developments
9.1.5. Business Strategy
9.2. Allscripts Healthcare Solutions, Inc.
9.2.1. Overview
9.2.2. Financial Overview
9.2.3. Product Offerings
9.2.4. Developments
9.2.5. Business Strategy
9.3. NXGN Management, LLC
9.3.1. Overview
9.3.2. Financial Overview
9.3.3. Product Offerings
9.3.4. Developments
9.3.5. Business Strategy
9.4. Koninklijke Philips N.V.
9.4.1. Overview
9.4.2. Financial Overview
9.4.3. Product Offerings
9.4.4. Developments
9.4.5. Business Strategy
9.5. McKesson Corporation
9.5.1. Overview
9.5.2. Financial Overview
9.5.3. Product Offerings
9.5.4. Developments
9.5.5. Business Strategy
9.6. Hill-Rom Services Inc.
9.6.1. Overview
9.6.2. Financial Overview
9.6.3. Product Offerings
9.6.4. Developments
9.6.5. Business Strategy
9.7. General Electric
9.7.1. Overview
9.7.2. Financial Overview
9.7.3. Product Offerings
9.7.4. Developments
9.7.5. Business Strategy
9.8. Cisco
9.8.1. Overview
9.8.2. Financial Overview
9.8.3. Product Offerings
9.8.4. Developments
9.8.5. Business Strategy
9.9. Stanly Healthcare
9.9.1. Overview
9.9.2. Financial Overview
9.9.3. Product Offerings
9.9.4. Developments
9.9.5. Business Strategy
9.10. ASCOM
9.10.1. Overview
9.10.2. Financial Overview
9.10.3. Product Offerings
9.10.4. Developments
9.10.5. Business Strategy

10. Analyst Opinion
11. Annexure
11.1. Report Scope
11.2. Market Definitions
11.3. Research Methodology
11.3.1. Data Collation and In-house Estimation
11.3.2. Market Triangulation
11.3.3. Forecasting
11.4. Report Assumptions
11.5. Declarations
11.6. Stakeholders
11.7. Abbreviations

ページTOPに戻る



List of Tables/Graphs

Tables
TABLE 1. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 2. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR DATA INTEGRATION, BY GEOGRAPHY , 2021-2030 (USD BILLION)
TABLE 3. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR REAL-TIME COMMUNICATION SOLUTIONS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 4. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR WORKFLOW AUTOMATION SOLUTIONS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 5. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR CARE COLLABORATION SOLUTIONS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 6. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR ENTERPRISE REPORTING & ANALYTICS SOLUTIONS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 7. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 8. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR HOSPITALS, 2021-2030 (USD BILLION)
TABLE 9. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR LONG-TERM CARE FACILITIES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 10. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR AMBULATORY CARE CENTERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 11. NORTH AMERICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 12. NORTH AMERICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 13. NORTH AMERICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 14. U.S CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 15. U.S CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 16. CANADA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 17. CANADA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 18. MEXICO CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 19. MEXICO CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 20. EUROPE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 21. EUROPE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 22. EUROPE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 23. GERMANY CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 24. GERMANY CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 25. U.K CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 26. U.K CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 27. FRANCE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 28. FRANCE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 29. ITALY CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 30. ITALY CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 31. SPAIN CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 32. SPAIN CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 33. ROE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 34. ROE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 35. ASIA PACIFIC CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 36. ASIA PACIFIC CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 37. ASIA PACIFIC CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 38. CHINA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 39. CHINA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 40. INDIA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 41. INDIA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 42. JAPAN CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 43. JAPAN CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 44. REST OF APAC CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 45. REST OF APAC CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 46. LATIN AMERICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 47. LATIN AMERICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 48. BRAZIL CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 49. BRAZIL CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 50. ARGENTINA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 51. ARGENTINA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 52. MIDDLE EAST AND AFRICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 53. MIDDLE EAST AND AFRICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 54. MIDDLE EAST AND AFRICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 55. SAUDI ARABIA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 56. SAUDI ARABIA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 57. UAE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 58. UAE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 59. REST OF MIDDLE EAST AND AFRICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 60. REST OF MIDDLE EAST AND AFRICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 61. CERNER CORPORATION: FINANCIALS
TABLE 62. CERNER CORPORATION: PRODUCTS & SERVICES
TABLE 63. CERNER CORPORATION: RECENT DEVELOPMENTS
TABLE 64. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: FINANCIALS
TABLE 65. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: PRODUCTS & SERVICES
TABLE 66. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: RECENT DEVELOPMENTS
TABLE 67. NXGN MANAGEMENT, LLC: FINANCIALS
TABLE 68. NXGN MANAGEMENT, LLC: PRODUCTS & SERVICES
TABLE 69. NXGN MANAGEMENT, LLC: RECENT DEVELOPMENTS
TABLE 70. KONINKLIJKE PHILIPS N.V.: FINANCIALS
TABLE 71. KONINKLIJKE PHILIPS N.V.: PRODUCTS & SERVICES
TABLE 72. KONINKLIJKE PHILIPS N.V.: RECENT DEVELOPMENTS
TABLE 73. MCKESSON CORPORATION: FINANCIALS
TABLE 74. MCKESSON CORPORATION: PRODUCTS & SERVICES
TABLE 75. MCKESSON CORPORATION: RECENT DEVELOPMENTS
TABLE 76. HILL-ROM SERVICES INC.: FINANCIALS
TABLE 77. HILL-ROM SERVICES INC.: PRODUCTS & SERVICES
TABLE 78. HILL-ROM SERVICES INC.: RECENT DEVELOPMENTS
TABLE 79. GENERAL ELECTRIC: FINANCIALS
TABLE 80. GENERAL ELECTRIC: PRODUCTS & SERVICES
TABLE 81. GENERAL ELECTRIC: DEVELOPMENTS
TABLE 82. CISCO: FINANCIALS
TABLE 83. CISCO: PRODUCTS & SERVICES
TABLE 84. CISCO: RECENT DEVELOPMENTS
TABLE 85. STANLY HEALTHCARE: FINANCIALS
TABLE 86. STANLY HEALTHCARE: PRODUCTS & SERVICES
TABLE 87. STANLY HEALTHCARE: RECENT DEVELOPMENTS
TABLE 88. ASCOM: FINANCIALS
TABLE 89. ASCOM: PRODUCTS & SERVICES
TABLE 90. ASCOM: RECENT DEVELOPMENTS

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

IHR Insights社の医療分野での最新刊レポート


よくあるご質問


IHR Insights社はどのような調査会社ですか?


IHR InsightsはICT、化学品、ヘルスケア、半導体など、世界の幅広い分野を対象に調査し、専門的な知識を基に市場調査報告書を出版しています。 主な調査分野 ◇ICT ◇化学品、材料、... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/14 10:27

156.77 円

166.04 円

201.95 円

ページTOPに戻る